These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 6100648)

  • 21. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
    Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
    N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunological findings in HTLV-III infection.
    Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
    Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pathogenic retrovirus (HTLV-III) linked to AIDS.
    Broder S; Gallo RC
    N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
    Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
    Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological trends of AIDS in the United States.
    Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW
    Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to human immuno-deficiency virus and human T-cell leukemia virus type I in Japanese patients with hematologic malignancies.
    Tobinai K; Minato K; Shimoyama M; Kawatani T; Kurimura T
    Jpn J Cancer Res; 1986 Dec; 77(12):1207-10. PubMed ID: 2880831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroepidemiological evidence for HTLV-III infection as the primary etiologic factor for acquired immunodeficiency syndrome.
    Sarngadharan MG; Schüpbach J; Bruch L; Devico A; Markham PD; Wong-Staal F; Gallo RC
    Prog Clin Biol Res; 1985; 182():309-27. PubMed ID: 2994105
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS in Haitian-Americans: a reassessment.
    Frank E; Weiss SH; Compas JC; Bienstock J; Weber J; Bodner A; Landesman SH
    Cancer Res; 1985 Sep; 45(9 Suppl):4619s-4620s. PubMed ID: 2990695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of HTLV-III antibodies using ELISA and the western blot].
    Kunz C; Heinz FX
    Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Properties and transmission of the AIDS virus].
    Laufs R
    Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection of neonates from transfusion-associated AIDS by the use of CMV-seronegative blood before availability of specific serologic tests for HTLV-III (HIV).
    Brady MT; Ng A
    Am J Perinatol; 1987 Oct; 4(4):305-7. PubMed ID: 2820434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

  • 38. Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III).
    Pandolfi F; De Rossi G; Mariani G; Carbonari M; Ensoli B; Napolitano M; Lopez M; Mandelli F; Aiuti F
    Diagn Immunol; 1985; 3(3):155-9. PubMed ID: 2996821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
    Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological characterization of HTLV-III infection in AIDS and related disorders.
    Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
    J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.